Abstract : Three different derivatives were obtained in the synthesis of cobaltbinding BLM-A2 and characterized by NMR and Mass spectrometry. It was found that Component 1 is Co(II)(2H 2 O)(BLM-A2), component 2 is Co(III)(OOH -)(BLM-A2) and component 3 is Co(III)(H 2 O)(OH -)(BLM-A2), respectively. Component 2 and 3 were interestingly dominated when CoBLM-A2 complex was synthesized under basic condition. In this experiment, it was revealed newly that the brown form (component 1) was 6-coordinated structure composed with not 5 ligands but 4 ligands from BLM-A2 and with 2H 2 O as the axial ligands. The component 3 exhibiting a novel ligand configuration is found, and the structure of component 3 was observed to be very similar to that of component 1 in the kind of their ligands but one of the axial ligand is OH -instead of H 2 O. These ligand configurations are different from the green form (component 2) exhibiting 6-coordinate structure composed of 5 ligands from BLM-A2 and one ligand of OOH -, being consistent with former studies.
INTRODUCTION
The antitumour antibiotic bleomycins (BLMs, Figure 1 ) are a group of glycopeptide-derived natural products originally isolated from Streptomyces verticillus by Umezawa and co-workers. 1 The clinically used BLMs is a mixture composed mainly of BLMs A2 and B2. The other minor 134 
Cobalt-binding BLM-A2 by NMR
components of BLMs are A1, A5, B4, demethyl A2 (DMBLM-A2) and bleomycinic acid. These BLMs are closely related water-soluble basic glycopeptides, which differ only in their terminal amine and has found utility against a variety of cancers, including nonHodgkins lymphomas, squamous cell carcinomas, and testicular tumors. Although this drug is widely used for cancer treatments, however, there have been many efforts to develop less toxic derivatives such as PEP because of pulmanary toxicity. and the primary nitrogen of the α-amino group of the β-aminoalanine portion is supposed to be the axial ligand 19 The therapeutic effectiveness of the BLMs is believed to derive from their ability to bind and oxidatively cleave cellular DNA, and possibly RNA, in the presence of certain metal ion cofactors [4] [5] [6] [7] [8] which by ULVAC Lyophilyzing system (model DF-03H-S, Japan). Dried BLM-A2 was dissolved in small amount of water and lyophilized again with being divided in several vials. We obtained 11.96 mg of BLM-A2, which was divided in 13 vials by equal amount (0.92 mg). The quantity was measured by titration which was added by Co(II) solution and checked by the residue of unreacted BLM-A2 by using ESI-mass. The spectroscopical properties and chromatographical purity of BLM-A2 were examined by NMR (Jeol, JNM-LA series, 400MHz, Japan), mass spectroscopy and HPLC.
EXPERIMENTAL METHODS

Materials and Reagents
Chromatographical purity was 95 % on HPLC chromatogram. On the 1 H-NMR spectrum and the HPLC chromatogram, there was detected some impurities which was probably resulted from degradation. CoBLM-A2 was formed well and fast comparatively. This method is so mild that the molecular can be detected with not losing any ligands during the analysis.
Synthesis of CoBLM-A2
RESULTS AND DISCUSSION
The 67.12 % of BLM-A2 was made immediately(within 2 or 5 minute) and 97 % at 1 hr elapsed and the reaction was made completely within 2 hrs after Co solution was added. 13 Also the stability of each compounds was examined for 14 or 7 days. Each component was stable for at least 14 days under pH 5 but component 2 and 3 were unstable under pH 7 or higher. By decreasing of component 2 and 3(2 was decreased more fast than 3), a new peak was appeared up and increased to some degrees and by more time elapsed, the peak 2, 3 and the new peak disappeared nearly completely in 7 days. 
CONCLUSION
In the synthesis of CoBLM-A2 complex, a mixture composed of two or more compounds were observed and characterized by 1 H-NMR and mass spectrometry. We were able to separate each component with HPLC by obtaining the peaks, mainly 2 peaks (nearly equal amount on HPLC chromatogram) and one small peak, separated clearly on chromatogram ( Figure 3 ). We found that at least 3 compounds of CoBLM-A2 were formed in the synthesis and monitored by NMR titration, and were able to identify each peak by mass spectroscopy. Stability tests were made by letting the complex solutions alone at room temperature for several days and performing ESI-mass. Further structural studies will be made by NMR experiments and NMR based molecular dynamic computations. [20] [21] [22] 
